share_log

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(31%),Matthew Friesen(31%), etc.

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(31%),Matthew Friesen(31%), etc.

Bruush Oral Care | SC 13D/A:超過5%持股股東披露文件(修正)-Yaletown Bros. Ventures Ltd.(31%),Matthew Friesen(31%)等
美股SEC公告 ·  02/05 17:19
Moomoo AI 已提取核心訊息
On January 30, 2024, Bruush Oral Care Inc. entered into a securities purchase agreement with Yaletown Bros. Ventures Ltd., involving the private placement of 33,000,000 pre-funded warrants. These warrants, exercisable at $0.001 per share, allow Yaletown Bros. Ventures Ltd. to acquire up to 33,000,000 shares of Bruush Oral Care's common stock. The transaction was completed on the same day, with the warrants being fully paid upon issuance. This agreement is part of Bruush Oral Care's broader investment management strategy and is not associated with any legal proceedings or violations of securities laws. The company has ensured compliance with all necessary regulatory requirements and has made provisions to maintain the required number of authorized but unissued shares to fulfill the warrants. The agreement also includes provisions for adjustments in the event of stock dividends, splits, or other corporate restructuring, as well as protections for the investors in case of a fundamental transaction such as a merger or sale of the company.
On January 30, 2024, Bruush Oral Care Inc. entered into a securities purchase agreement with Yaletown Bros. Ventures Ltd., involving the private placement of 33,000,000 pre-funded warrants. These warrants, exercisable at $0.001 per share, allow Yaletown Bros. Ventures Ltd. to acquire up to 33,000,000 shares of Bruush Oral Care's common stock. The transaction was completed on the same day, with the warrants being fully paid upon issuance. This agreement is part of Bruush Oral Care's broader investment management strategy and is not associated with any legal proceedings or violations of securities laws. The company has ensured compliance with all necessary regulatory requirements and has made provisions to maintain the required number of authorized but unissued shares to fulfill the warrants. The agreement also includes provisions for adjustments in the event of stock dividends, splits, or other corporate restructuring, as well as protections for the investors in case of a fundamental transaction such as a merger or sale of the company.
2024年1月30日,Bruush Oral Care Inc.與Yaletown Bros. Ventures Ltd.簽署了證券購買協議,涉及3300萬股的定向增發。這些行權價爲每股0.001美元的認購權讓Yaletown Bros. Ventures Ltd.可以獲得33,000,000股Bruush Oral Care普通股的權益。交易在當天完成,認購權發行時已完全支付。該協議是Bruush Oral Care更廣泛的投資管理策略的一部分,不涉及任何法律訴訟或違反證券法的行爲。公司已確保遵守所有必要的監管要求,並做好了維持已授權但未發行股份的數量以充分實現認購權的規定。該協議還包括在股票送轉、分割或其他公司重組事件發生時進行調整的條款,以及在發生基本交易(如公司合併或出售)情況下,爲投資者提供保護的條款。
2024年1月30日,Bruush Oral Care Inc.與Yaletown Bros. Ventures Ltd.簽署了證券購買協議,涉及3300萬股的定向增發。這些行權價爲每股0.001美元的認購權讓Yaletown Bros. Ventures Ltd.可以獲得33,000,000股Bruush Oral Care普通股的權益。交易在當天完成,認購權發行時已完全支付。該協議是Bruush Oral Care更廣泛的投資管理策略的一部分,不涉及任何法律訴訟或違反證券法的行爲。公司已確保遵守所有必要的監管要求,並做好了維持已授權但未發行股份的數量以充分實現認購權的規定。該協議還包括在股票送轉、分割或其他公司重組事件發生時進行調整的條款,以及在發生基本交易(如公司合併或出售)情況下,爲投資者提供保護的條款。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息